Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Potential Role of SARS-COV-2 in the Pathogenesis of Parkinson's Disease
Pedro Chaná‐Cuevas, Philippe Salles-Gándara, Alejandro Rojas‐Fernández, et al.
Frontiers in Neurology (2020) Vol. 11
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Epidemiology and organ specific sequelae of post-acute COVID19: A narrative review
Eleni Korompoki, Maria Gavriatopoulou, Rachel Hicklen, et al.
Journal of Infection (2021) Vol. 83, Iss. 1, pp. 1-16
Open Access | Times Cited: 158
Role of medicinal plants in inhibiting SARS-CoV-2 and in the management of post-COVID-19 complications
Pulok K. Mukherjee, Thomas Efferth, Bhaskar Das, et al.
Phytomedicine (2022) Vol. 98, pp. 153930-153930
Open Access | Times Cited: 53
SARS-CoV-2 Proteins Interact with Alpha Synuclein and Induce Lewy Body-like Pathology In Vitro
Zhengcun Wu, Xiuao Zhang, Zhangqiong Huang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3394-3394
Open Access | Times Cited: 49
Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms
Pei Huang, Linyuan Zhang, Yuyan Tan, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 29
Parkinsonism in viral, paraneoplastic, and autoimmune diseases
Frank Xing, Luca Marsili, Daniel Truong
Journal of the Neurological Sciences (2021) Vol. 433, pp. 120014-120014
Closed Access | Times Cited: 49
Ginkgo Biloba and Long COVID: In Vivo and In Vitro Models for the Evaluation of Nanotherapeutic Efficacy
Thelma Akanchise, Angelina Angelova
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1562-1562
Open Access | Times Cited: 16
Emerging Neurological and Psychobiological Aspects of COVID-19 Infection
Lyubka Tancheva, Maria Cristina Petralia, Simona Miteva, et al.
Brain Sciences (2020) Vol. 10, Iss. 11, pp. 852-852
Open Access | Times Cited: 41
Possible Link between SARS-CoV-2 Infection and Parkinson’s Disease: The Role of Toll-Like Receptor 4
Carmela Conte
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7135-7135
Open Access | Times Cited: 33
Bioinformatics and system biology approaches to identify pathophysiological impact of COVID-19 to the progression and severity of neurological diseases
Md Habibur Rahman, Humayan Kabir Rana, Silong Peng, et al.
Computers in Biology and Medicine (2021) Vol. 138, pp. 104859-104859
Open Access | Times Cited: 33
COVID-19 and Parkinsonism: A Critical Appraisal
Francesco Cavallieri, Valentina Fioravanti, Francesco Bove, et al.
Biomolecules (2022) Vol. 12, Iss. 7, pp. 970-970
Open Access | Times Cited: 26
Impacto del COVID-19 en el desempeño cognitivo de los pacientes recuperados al año de la infección: estudio de cohortes utilizando la herramienta MoCA-T
Sandra Marcela Cardona Moica, Loida Camargo, Enrique Carlos Ramos Clason, et al.
Neurología Argentina (2025)
Closed Access
Ecofriendly micellar mediated spectrofluorimetric method for ultrasensitive quantification of the antiparkinsonian drug safinamide in pharmaceutical formulation and spiked human plasma
Engy A. Ibrahim, Hoda M. Marzouk, Maha A. Hegazy, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Protein clearance strategies for disease intervention
Franziska Hommen, Saygın Bilican, David Vı́lchez
Journal of Neural Transmission (2021) Vol. 129, Iss. 2, pp. 141-172
Open Access | Times Cited: 22
Nervous System Involvement in COVID-19: a Review of the Current Knowledge
Mahnaz Norouzi, Paniz Miar, Shaghayegh Norouzi, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 7, pp. 3561-3574
Open Access | Times Cited: 18
Assessment of the relationship between the dopaminergic pathway and severe acute respiratory syndrome coronavirus 2 infection, with related neuropathological features, and potential therapeutic approaches in COVID‐19 infection
Yousef Rasmi, Ameneh Shokati, Shima Hatamkhani, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 1
Closed Access | Times Cited: 2
SARS-COV-2 induced Parkinsonism: The first case from the sub-Saharan Africa
Biniyam A. Ayele, Hanna Demissie, Meron Awraris, et al.
Clinical Parkinsonism & Related Disorders (2021) Vol. 5, pp. 100116-100116
Open Access | Times Cited: 17
Anxiety and depression in COVID-19: treatment options
В. Э. Медведев
Neurology neuropsychiatry Psychosomatics (2021) Vol. 13, Iss. 2, pp. 111-116
Open Access | Times Cited: 16
Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery
Yu Wu, Miora Rakotoarisoa, Borislav Angelov, et al.
Nanomaterials (2022) Vol. 12, Iss. 13, pp. 2267-2267
Open Access | Times Cited: 12
Structure-constrained combination-based nonlinear association analysis between incomplete multimodal imaging and genetic data for biomarker detection of neurodegenerative diseases
Xiumei Chen, Tao Wang, Haoran Lai, et al.
Medical Image Analysis (2022) Vol. 78, pp. 102419-102419
Closed Access | Times Cited: 11
Parkinson’s Disease and SARS-CoV-2 Infection: Particularities of Molecular and Cellular Mechanisms Regarding Pathogenesis and Treatment
Aurelian Anghelescu, Gelu Onose, Cristina Raluca Gh. Popescu, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1000-1000
Open Access | Times Cited: 11
Neuropathological Aspects of SARS-CoV-2 Infection: Significance for Both Alzheimer’s and Parkinson’s Disease
Jaime R. Silva, Felipe Patricio, Aleidy Patricio-Martínez, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 11
Tumoral parkinsonism—Parkinsonism secondary to brain tumors, paraneoplastic syndromes, intracranial malformations, or oncological intervention, and the effect of dopaminergic treatment
Gustav Cedergren Weber, Jonathan Timpka, Anna Rydelius, et al.
Brain and Behavior (2023) Vol. 13, Iss. 8
Open Access | Times Cited: 6
Peripheral Immune Cell Numbers and C-Reactive Protein in Parkinson’s Disease: Results from a Population-Based Study
Lisanne J. Dommershuijsen, Rikje Ruiter, Nicole S. Erler, et al.
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 2, pp. 667-678
Open Access | Times Cited: 15
Methodologies for Generating Brain Organoids to Model Viral Pathogenesis in the CNS
Hannah K. Hopkins, Elizabeth M. Traverse, Kelli L. Barr
Pathogens (2021) Vol. 10, Iss. 11, pp. 1510-1510
Open Access | Times Cited: 14
Astenic disorders within the framework of post-covid syndrome
В. Э. Медведев, В И Фролова, E V Gushanskaya, et al.
S S Korsakov Journal of Neurology and Psychiatry (2021) Vol. 121, Iss. 4, pp. 152-152
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top